Bio Blast Pharma Balance Sheet - Annual (NASDAQ:ORPN)

Add to My Stocks
$1.3 $0.04 (2.99%) ORPN stock closing price Sep 20, 2018 (Closing)

The Bio Blast Pharma balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. Financial strength can be guaged by performing Bio Blast Pharma stock analysis and by analyzing the balance sheet. Annual results are typically accompanied with the company releasing financial statements. Bio Blast Pharma balance sheet indicates an asset turnover ratio of and debt to equity ratio of . Also check Bio Blast Pharma revenue and Bio Blast Pharma operating cash flow for the same period.

View latest 10 year balance sheet data to check Bio Blast Pharma financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Cash3.52M6.87M7.28M10.58M--
Marketable Securities-3M12.04M22.02M--
Receivables--1.06M---
Inventory------
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets------
Total Current Assets
3.62M10.54M20.39M32.88M--
Property Plant & Equipment------
Accumulated Depreciation------
Net Property Plant & Equipment
------
Investment & Advances------
Other Non-Current Assets------
Deferred Charges------
Intangibles------
Deposits & Other Assets------
Total Assets
3.62M10.63M20.51M32.95M--
Notes Payable------
Accounts Payable--1.41M1.28M--
Current Portion Long-Term Debt------
Current Portion Capital Leases------
Accrued Expenses------
Income Taxes Payable------
Other Current Liabilities-1.23M1.1M---
Total Current Liabilities
-1.93M2.51M2.28M--
Mortgages------
Deferred Taxes/Income------
Convertible Debt------
Long-Term Debt------
Non-Current Capital Leases------
Other Long-Term Liabilities------
Total Liabilities
-1.93M2.58M2.28M--
Minority Interest------
Preferred Stock------
Common Stock Net------
Capital Surplus48.87M48.46M41.68M39.05M1.55M-
Retained Earnings-45.75M-39.8M-23.78M-8.42M-1.4M-0.22M
Treasury Stock------
Other Liabilities------
Shareholders Equity3.16M8.69M17.93M30.67M--
Total Liabilities & Shareholders Equity3.62M10.63M20.51M32.95M--
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Galmed Pharma financial analysis

Most investors just check the Bio Blast Pharma stock price, and Bio Blast Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Bio Blast Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Bio Blast Pharma owns and has monetary significance. ORPN assets decreased from $10.63M in 2016 to $3.62M in 2017. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: The total liabilities of Bio Blast Pharma for the year 2017 total to $-. Liabilities for a company like Bio Blast Pharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Bio Blast Pharma Balance Sheet - Key Ratios